Factors influencing work disability in psoriatic arthritis: First results from a large UK multicentre study

Rheumatology (United Kingdom)

Volumn 54, Issue 1, 2014, Pages 157-162

  Tillett, William ^a   Shaddick, Gavin ^b   Askari, Ayman ^c   Cooper, Annie ^d   Creamer, Paul ^e   Clunie, Gavin ^f   Helliwell, Philip S ^g   Kay, Lesley ^h   Korendowych, Eleanor ^a   Lane, Suzanne ⁱ   Packham, Jonathan ^j   Shaban, Ragai ^k   Williamson, Lyn ^l   McHugh, Neil ^m  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b University of Bath   (United Kingdom)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^e NORTH BRISTOL NHS TRUST   (United Kingdom)

^f CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^h NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^j HAYWOOD HOSPITAL   (United Kingdom)

^k QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^l GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m University of Bath   (United Kingdom)

more..

Author keywords

Employment; Psoriatic arthritis; Work disability

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; COOPERATION; DISEASE ACTIVITY; DISEASE DURATION; EMPLOYMENT; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRESENTEEISM; PRIORITY JOURNAL; PRODUCTIVITY; PSORIATIC ARTHRITIS; SOCIOECONOMICS; UNEMPLOYMENT; UNITED KINGDOM; WORK; WORK DISABILITY;

EID: 84928740424     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu264     Document Type: Article

References (16)

1. Husted JA, Gladman DD, Farewell VT et al. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
2. Short P, Jones AC, Walker D et al. Working at arthritis. Rheumatology 2012;51:201-3.
3. Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology 2012;51:275-83.
4. Zhang W, Bansback N, Boonen A et al. Validity of the work productivity and activity impairment questionnaire- general health version in patients with rheumatoid arthritis. Arthritis Res Ther 2010;12:R177.
5. Schoels M, Aletaha D, Funovits J et al. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010;69:1441-7.
6. Wassenberg S, Fischer-Kahle V, Herborn G et al. A method to score radiographic change in psoriatic arthritis. Z Rheumatol 2001;60:156-66.
7. Verstappen SM, Watson KD, Lunt M et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology 2010;49: 1570-7.
8. Nikiphorou E, Guh D, Bansback N et al. Work disability rates in RA. Results from an inception cohort with 24 years follow-up. Rheumatology 2012;51:385-92.
9. Kristensen LE, Englund M, Neovius M et al. Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. Ann Rheum Dis 2013;72: 1675-9.
10. Mau W, Listing J, Huscher D et al. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721-8.
11. Wallenius M, Skomsvoll JF, Koldingsnes W et al. Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis 2009;68: 685-9.
12. Gladman DD, Bombardier C, Thorne C et al. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. J Rheumatol 2011;38:1355-62.
13. Kavanaugh A, McInnes IB, Krueger GG et al. Patient reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of the GOREVEAL trial. Arthritis Care Res 2013;65:1666-73.
14. Christophers E, Barker JN, Griffiths CE et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010; 24:548-54.
15. Radtke MA, Reich K, Blome C et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009;23: 683-91.
16. Tillett W, Shaddick G, Korendowych E et al. Joint count reliability in psoriatic arthritis observational trials-an unreported problem. Rheumatology 2012;51:1333-4.